Cumberland Pharmaceuticals (CPIX) Common Equity (2016 - 2025)
Historic Common Equity for Cumberland Pharmaceuticals (CPIX) over the last 17 years, with Q3 2025 value amounting to $26.1 million.
- Cumberland Pharmaceuticals' Common Equity rose 541.09% to $26.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $26.1 million, marking a year-over-year increase of 541.09%. This contributed to the annual value of $22.9 million for FY2024, which is 2280.12% down from last year.
- According to the latest figures from Q3 2025, Cumberland Pharmaceuticals' Common Equity is $26.1 million, which was up 541.09% from $28.0 million recorded in Q2 2025.
- Over the past 5 years, Cumberland Pharmaceuticals' Common Equity peaked at $48.0 million during Q2 2021, and registered a low of $22.9 million during Q4 2024.
- Moreover, its 5-year median value for Common Equity was $36.3 million (2022), whereas its average is $34.9 million.
- In the last 5 years, Cumberland Pharmaceuticals' Common Equity crashed by 3115.3% in 2024 and then surged by 622.72% in 2025.
- Cumberland Pharmaceuticals' Common Equity (Quarter) stood at $42.8 million in 2021, then dropped by 15.29% to $36.3 million in 2022, then decreased by 18.37% to $29.6 million in 2023, then fell by 22.8% to $22.9 million in 2024, then increased by 14.29% to $26.1 million in 2025.
- Its Common Equity was $26.1 million in Q3 2025, compared to $28.0 million in Q2 2025 and $28.7 million in Q1 2025.